Prosecution Insights
Last updated: October 04, 2026

S&G Biotech Inc.

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

S&G Biotech Inc. is active in the Medical Devices & Mechanical Engineering technology area with a portfolio that currently includes 1 pending office action. This action is being handled by 1 distinct examiner, THOMAS, NATALIE NICOLE, who is the busiest examiner for the company. The 1 pending office action constitutes the entirety of the current prosecution workload for this examiner.

The portfolio's activity is limited to 1 distinct art unit, which suggests a focused technical scope for the pending matters. For a practitioner, the concentration of the pending workload under 1 distinct examiner simplifies the prosecution process. There are no competing examiner styles or art unit requirements to manage. Instead, the strategy revolves around the 1 pending office action and the specific feedback from THOMAS, NATALIE NICOLE. This centralized structure allows for a targeted approach to securing intellectual property rights within the Medical Devices & Mechanical Engineering sector, with the outcome tied to this 1 examination path.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
THOMAS, NATALIE NICOLE 1 — —

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18215478 STENT DELIVERY DEVICE THOMAS, NATALIE NICOLE 1d overdue

Top Art Units

Art UnitApps
3774 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18215478 STENT DELIVERY DEVICE THOMAS, NATALIE NICOLE 3774 §102§103§112 Non-Final OA 1d overdue Pending Jun 28, 2023

Managing S&G Biotech Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month